Healthcare

We committed to investing in healthcare and we've put significant effort into developing machine intelligence to help achieve our goals. Together with our partners, we aim to provide a sustainable pathway to Value-Based Healthcare. Our approach helps in computer-aided diagnosis and links care processes and care paths to support therapy decisions based on patient-reported outcomes and the associated total costs of treatment. But there's always room to do more.

Chartel Group continues to study the application of machine intelligence in diagnosis, predictive and preemptive medicine. To date, our efforts have yielded good results particularly in Autism Screening, Diabetic Retinotherapy and Human Bone Disorder and we continue to work closely with our partners to advance our research in Breast Cancer detection, DNA Classification, Heart Disease prediction and other fields.

We want to make otherwise inaccessible solutions readily available and affordable.
A healthy Africa is a prosperous Africa.